Ngoc N. Lunde
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Legumain is a paracrine regulator of osteoblast differentiation and mediates the inhibitory effect of TGF-β1 on osteoblast maturation.
Journal: Frontiers in endocrinology
Published: June 06, 2024
Interplay between Cultured Human Osteoblastic and Skeletal Muscle Cells: Effects of Conditioned Media on Glucose and Fatty Acid Metabolism.
Journal: Biomedicines
Published: September 12, 2023
The Mammalian Cysteine Protease Legumain in Health and Disease.
Journal: International journal of molecular sciences
Published: October 28, 2022
Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
Journal: Journal of the American Heart Association
Published: August 19, 2020
Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages.
Journal: Atherosclerosis
Published: April 15, 2019
Mammalian legumain - A lysosomal cysteine protease with extracellular functions?
Journal: Biochimie
Published: February 21, 2019
Glycosylation is important for legumain localization and processing to active forms but not for cystatin E/M inhibitory functions.
Journal: Biochimie
Published: March 21, 2017
Increased levels of legumain in plasma and plaques from patients with carotid atherosclerosis.
Journal: Atherosclerosis
Published: September 02, 2016
Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes.
Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes.
Journal: Cell chemical biology
Published: March 01, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026